Laboratory Corporation of America Holdings (LH)
NYSE · Healthcare · Diagnostics & Research
Laboratory Corporation of America Holdings is a Healthcare company with a market capitalization of $26.01B, a trailing P/E ratio of 26.5, and a dividend yield of 0.89%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 30, 2026 | $4.25 | $4.12 | +3.2% |
| Q4 2025 | February 17, 2026 | $4.07 | $3.94 | +3.3% |
| Q3 2025 | October 28, 2025 | $4.18 | $4.14 | +1.0% |
| Q2 2025 | July 24, 2025 | $4.35 | $4.16 | +4.6% |
| Q1 2025 | April 29, 2025 | $3.84 | $3.73 | +2.9% |
| Q4 2024 | February 6, 2025 | $3.45 | $3.39 | +1.8% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 2,721,939 | 3.28% | 4.7 | -3.8% |
| June 30, 2026 | 2,830,398 | 3.41% | 3.8 | -13.3% |
| June 15, 2026 | 3,264,521 | 3.94% | 6.0 | -4.7% |
| May 29, 2026 | 3,426,602 | 4.13% | 5.8 | +1.7% |
| May 15, 2026 | 3,369,697 | 4.06% | 4.7 | +6.8% |
| April 30, 2026 | 3,156,205 | 3.81% | 4.1 | -2.5% |
| April 15, 2026 | 3,236,989 | 3.89% | 6.0 | +1.4% |
| March 31, 2026 | 3,192,818 | 3.84% | 5.5 | +6.7% |
Other Diagnostics & Research Stocks
Frequently Asked Questions
What is Laboratory Corporation of America Holdings's market cap?
As of August 13, 2026, Laboratory Corporation of America Holdings (LH) has a market capitalization of $26.01B.
What is Laboratory Corporation of America Holdings's P/E ratio?
Laboratory Corporation of America Holdings trades at a trailing price-to-earnings (P/E) ratio of 26.5. Its forward P/E is 17.7.
Does Laboratory Corporation of America Holdings pay a dividend?
Yes — Laboratory Corporation of America Holdings pays a dividend yielding 0.89%, an annual payout of $2.88 per share.
What sector is LH in?
Laboratory Corporation of America Holdings is in the Healthcare sector, specifically the Diagnostics & Research industry.
What is Laboratory Corporation of America Holdings's short interest?
As of the July 15, 2026 FINRA settlement, 2,721,939 LH shares were sold short, or 3.28% of shares outstanding. Days to cover: 4.7. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was Laboratory Corporation of America Holdings's revenue?
In its latest reported fiscal year (ending December 31, 2025), Laboratory Corporation of America Holdings reported revenue of $13.95B and net income of $876.50M.
Ask your own questions about LH
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.